Pr revious reports suggest that gene therapy may be used to treat inherited and acquired disease processes.' A variety of cell types have been genetically modified and introduced into animals2-6 and, recently, humans.7 The applicability of this strategy to the cardiovascular system has been demonstrated by Wilson et Although the approach of reintroducing genetically altered endothelial cells into arterial segments is promising, it is limited in humans by the practical aspects of obtaining endothelial cells in advance from individual patients and transfecting and selecting cells in vitro before the reintroduction into vascular segments. Direct gene transfer into vascular segments obviates these problems. Previous reports indicate the feasibility of direct gene transfer in situ into organs and tissues by infection with retroviruses," direct injection of DNA and RNA into See p 2133 tissues,12 and either injection into13 or incubation of tissues with DNA-lipid complexes.14 Recently, Nabel et al15 demonstrated direct gene transfer in vivo by both retroviral infection and liposome-mediated transfection into pig iliofemoral vascular segments.
The marker gene product, f3-galactosidase, could be detected for at least 5 MgCl2 , and 1 mM DTT, pH 7.8). After centrifugation, the pellet was resuspended in extraction buffer containing 1.0% NP40. For the analysis of arterial segments, tissue was washed in PBS, minced with a scalpel, and homogenized at 4°C in extraction buffer containing 0.2% NP40. The volume of the lysate varied from 0.5 to 1.0 ml depending on the weight of the arterial segment harvested. The cell and tissue extracts were incubated at 4°C for 5 minutes, and then centrifuged.
An aliquot of the supernatant (50 ,ul) was mixed in 250 ,gl of assay buffer (50 mM glycylglycine, pH 7.8, 20 mM MgSO4, 0.1 mg BSA, 12 mM EDTA, 2 mM ATP, and 1 mM DTT), 100 ,ul 0.5 mM luciferin was added to initiate the reaction, and peak light emission was measured for 10 seconds at 25°C using a luminometer (Biolumat LB9500C, Berthold Analytical Instruments, Inc., Nashua, N.H.). Each sample was assayed a minimum of three times. Total light units per sample were calculated and adjusted for background activity as measured in the supernatant from the nontransfected artery. This background activity varied from 0 to 42 light units, with a mean of 13 light units (corresponding to 0.4 pg luciferase). The activity of each sample was expressed in picograms of luciferase by comparing values with a standard curve (30 light units/pg luciferase). The luciferase activity of the samples was demonstrated to be within the linear range of the assay.
Cell Culture and In Vitro Transfection
Canine endothelial cell primary cultures were prepared using previously described techniques.22 Canine external jugular veins were harvested and stored at 4°C in PBS until processing. The lumen was cannulated, the distal end was occluded, and the vessel was filled with 0.1% type II collagenase (Worthington Biochemical Corp., Freehold, N.J.). After incubation at 37°C for 15 minutes, the lumen was perfused with 10 ml of culture media (Dulbecco's Modified Eagle's Media [DMEM] containing 10% fetal bovine serum [FBS] ). The perfusate was centrifuged at 500 rpm for 5 minutes; then the endothelial cells were resuspended and plated into tissue culture dishes. Media was supplemented with 100 ,ug of endothelial cell growth factor (Collaborative Research, Inc., Bedford, Mass.), and cells were studied within four passages. Endothelial cells were identified by their cobblestone morphology and reactivity with anti-factor VIII antibody.
Endothelial cells were grown to approximately 80% confluence in 10-cm dishes, the media was aspirated, and the cells were washed three times in PBS. Thirty micrograms of the plasmid containing the luciferase cDNA was mixed with 90 ,ul of synthetic cationic lipid preparation (Lipofectin) in 4 ml of OptiMem buffer (Bethesda Research Laboratories, Gaithersburg, Md.) and applied to the dishes for the length of time indicated. After incubation, the DNA/Lipofectin solution was aspirated, DMEM containing 10% FBS was added, and cells were cultured for 72 hours before assaying for luciferase activity. After demonstrating the feasibility of short transfection times for lipid-mediated gene transfer, we applied this technique to canine femoral arteries in vivo. In 10 animals, lac-Z plasmid plus Lipofectin mixture was introduced into one to four arterial segments in each animal; after 24 hours, ,B-galactosidase-like activity was assessed in the transfected artery and in nontransfected arterial segments. In six of these animals, an additional control was performed by incubating an arterial segment with Lipofectin alone. As evident in Table 2 , although fl-galactosidase-like activity was observed in 13 of 18 arterial segments, activity was also detectable in three of 11 nontransfected segments and in four of six segments undergoing mock transfection with Lipofectin alone. In three animals, the intensity of color development in the mock-transfected vessel (Lipofectin alone) was equal to that observed in the artery incubated with lac-Z plasmid plus Lipofectin. These results suggest that 13-galactosidase may not be an appropriate marker protein for expression studies in the canine vasculature.
In Vivo Transfection ofArteral Segments
Although the results of the experiments with the lac-Z reporter gene suggested that gene transfer occurred, the results were not conclusive because of 
